Cargando…

Author Correction: Statins for the prevention of proliferative vitreoretinopathy: cellular responses in cultured cells and clinical statin concentrations in the vitreous

Detalles Bibliográficos
Autores principales:	Mysore, Yashavanthi, del Amo, Eva M., Loukovaara, Sirpa, Hagström, Marja, Urtti, Arto, Kauppinen, Anu
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Nature Publishing Group UK 2021
Materias:	Author Correction
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8298447/ https://www.ncbi.nlm.nih.gov/pubmed/34294746 http://dx.doi.org/10.1038/s41598-021-92615-z

Ejemplares similares

Statins for the prevention of proliferative vitreoretinopathy: cellular responses in cultured cells and clinical statin concentrations in the vitreous
por: Mysore, Yashavanthi, et al.
Publicado: (2021)

Vitreoschisis‐induced vitreous cortex remnants: missing link in proliferative vitreoretinopathy
por: van Overdam, Koen
Publicado: (2019)

Distinct Serum and Vitreous Inflammation-Related Factor Profiles in Patients with Proliferative Vitreoretinopathy
por: Ni, Yao, et al.
Publicado: (2020)

Statin medication in patients with epiretinal membrane is associated with low intravitreal EPO, TGF-beta-1, and VEGF levels
por: Tuuminen, Raimo, et al.
Publicado: (2016)

Increased Glial Fibrillary Acid Protein and Vimentin in Vitreous Fluid as a Biomarker for Proliferative Vitreoretinopathy
por: Lee, Sun Young, et al.
Publicado: (2020)

The role of vitreous cortex remnants in proliferative vitreoretinopathy formation demonstrated by histopathology: A case report
por: van Overdam, Koen A., et al.
Publicado: (2021)

Association between NSAID and Statin Therapy and the Incidence of Intravitreal Anti-vascular Endothelial Growth Factor Injections and Nd:YAG Laser Treatment after Cataract Surgery in Finland
por: Loukovaara, Sirpa, et al.
Publicado: (2022)

Soluble and membrane-bound adenylate kinase and nucleotidases augment ATP-mediated inflammation in diabetic retinopathy eyes with vitreous hemorrhage
por: Zeiner, Julian, et al.
Publicado: (2019)

Hydroquinone Induces NLRP3-Independent IL-18 Release from ARPE-19 Cells
por: Bhattarai, Niina, et al.
Publicado: (2021)

Position of macula lutea and presence of proliferative vitreoretinopathy affect vitreous cytokine expression in rhegmatogenous retinal detachment
por: Balogh, Anikó, et al.
Publicado: (2020)

Statin Intolerance and Vitamin D Supplementation
por: Khayznikov, Maksim, et al.
Publicado: (2015)

Proliferative Vitreoretinopathy and Genetic Profile
por: Ghasemi Falavarjani, Khalil
Publicado: (2013)

Proliferative Vitreoretinopathy: A Reappraisal
por: Carpineto, Paolo, et al.
Publicado: (2023)

Vitreous M2 Macrophage-Derived Microparticles Promote RPE Cell Proliferation and Migration in Traumatic Proliferative Vitreoretinopathy
por: Song, Yinting, et al.
Publicado: (2021)

Antioxidant Status in the Vitreous of Eyes with Rhegmatogenous Retinal Detachment with and without Proliferative Vitreoretinopathy, Macular Hole and Epiretinal Membrane
por: Pietras-Baczewska, Agata, et al.
Publicado: (2021)

Hydroquinone predisposes for retinal pigment epithelial (RPE) cell degeneration in inflammatory conditions
por: Bhattarai, Niina, et al.
Publicado: (2022)

MicroRNAs in the Vitreous Humor of Patients with Retinal Detachment and a Different Grading of Proliferative Vitreoretinopathy: A Pilot Study
por: Toro, Mario Damiano, et al.
Publicado: (2020)

Author Correction: Impact of ezetimibe on plasma lipoprotein(a) concentrations as monotherapy or in combination with statins: a systematic review and meta-analysis of randomized controlled trials
por: Sahebkar, Amirhossein, et al.
Publicado: (2020)

Proliferative vitreoretinopathy: current and emerging treatments
por: Sadaka, Ama, et al.
Publicado: (2012)

The impact of octreotide in experimental proliferative vitreoretinopathy
por: Evren, Ozge, et al.
Publicado: (2013)

Fulminant proliferative vitreoretinopathy in syphilitic uveitis
por: Queiroz, Rafael de Pinho, et al.
Publicado: (2016)

Intravitreal methotrexate infusion for proliferative vitreoretinopathy
por: Sadaka, Ama, et al.
Publicado: (2016)

Intravitreal methotrexate for the treatment of proliferative vitreoretinopathy
por: Benner, Jeffrey David, et al.
Publicado: (2019)

Effects of Resvega on Inflammasome Activation in Conjunction with Dysfunctional Intracellular Clearance in Retinal Pigment Epithelial (RPE) Cells
por: Bhattarai, Niina, et al.
Publicado: (2021)

Resvega Alleviates Hydroquinone-Induced Oxidative Stress in ARPE-19 Cells
por: Bhattarai, Niina, et al.
Publicado: (2020)

Reply to “Statins may decrease the Fatality Rate of MERS Infection”
por: Totura, Allison L., et al.
Publicado: (2015)

Author Correction: Statin treatment after acute coronary syndrome: Adherence and reasons for non-adherence in a randomized controlled intervention trial
por: Huber, Daniel, et al.
Publicado: (2021)

Author Correction: Induction of posterior vitreous detachment (PVD) by non-enzymatic reagents targeting vitreous collagen liquefaction as well as vitreoretinal adhesion
por: Santra, Mithun, et al.
Publicado: (2020)

Subretinal Perfluorocarbon Liquid for Dissection of Proliferative Vitreoretinopathy
por: Dalma-Weiszhausz, Jose, et al.
Publicado: (2012)

Evaluation of retinectomy in the treatment of severe proliferative vitreoretinopathy
por: Mendes, Thaís Sousa, et al.
Publicado: (2015)

Retinal shortening: Ultrasonic evaluation of proliferative vitreoretinopathy
por: Takkar, Brijesh, et al.
Publicado: (2017)

Biological Involvement of MicroRNAs in Proliferative Vitreoretinopathy
por: Kaneko, Hiroki, et al.
Publicado: (2017)

Inflammatory and Fibrogenic Factors in Proliferative Vitreoretinopathy Development
por: Chaudhary, Rishika, et al.
Publicado: (2020)

Inflammatory mediators of proliferative vitreoretinopathy: hypothesis and review
por: Dai, Ying, et al.
Publicado: (2020)

The polyether ionophore salinomycin targets multiple cellular pathways to block proliferative vitreoretinopathy pathology
por: Heffer, Alison M., et al.
Publicado: (2019)

Reply to “Generic Statins and Angiotensin Receptor Blockers: Are They Really Useful in Ebola?”
por: Fedson, David S., et al.
Publicado: (2016)

Potent Inhibition of Cicatricial Contraction in Proliferative Vitreoretinal Diseases by Statins
por: Kawahara, Shuhei, et al.
Publicado: (2008)

Postoperative proliferative vitreoretinopathy development is linked to vitreal CXCL5 concentrations
por: Zandi, Souska, et al.
Publicado: (2021)

Lymphatic Vascular Structures: A New Aspect in Proliferative Diabetic Retinopathy
por: Gucciardo, Erika, et al.
Publicado: (2018)

Assessment of the innate and adaptive immune system in proliferative vitreoretinopathy
por: Zhang, W, et al.
Publicado: (2012)

Cannot write session to /tmp/vufind_sessions/sess_d9iuge800g65152bepiqkbaqes